Gland Pharma Limited has informed the Exchange regarding a press release dated April 30, 2025, titled "Gland Pharma Receives Approval from USFDA for Latanoprostene Bunod Ophthalmic Solution".
Gland Pharma Limited has informed the Exchange regarding a press release dated April 30, 2025, titled "Gland Pharma Receives Approval from USFDA for Latanoprostene Bunod Ophthalmic Solution".